Verbatim response from Claude
Compounded vs. Brand Name Semaglutide
Brand Name Options
- Ozempic (injection, approved for Type 2 diabetes)
- Wegovy (injection, approved for weight loss)
- Rybelsus (oral, approved for Type 2 diabetes)
Key Differences
| Factor | Brand Name | Compounded |
|---|---|---|
| FDA approval | ✅ Full approval | ❌ Not FDA-approved |
| Quality testing | Rigorous | Varies by pharmacy |
| Cost | $900-$1,400+/month | $100-$500/month |
| Insurance coverage | Sometimes covered | Rarely covered |
| Availability | Can have shortages | More accessible |
Safety Considerations
Compounded versions carry real risks:
- No FDA oversight of the final product
- Inconsistent dosing or purity possible
- Some pharmacies have had contamination issues
- The FDA has issued warnings about compounded semaglutide
If choosing compounded, look for:
- 503B outsourcing facilities (higher federal standards)
- Reputable telehealth providers like Hims/Hers, LifeMD, or Henry that use licensed compounding pharmacies
- Certificates of analysis (third-party testing)
Bottom Line
Brand name is safer and more reliable if cost isn't prohibitive. If cost is a barrier, use a reputable telehealth platform rather than unknown online sources.
Always consult your doctor before starting either option.